About Us
Biocodex at a glance
Present in more than 120 countries, Biocodex’s 1,626 employees are committed to serving millions of patients around the world. We apply our expertise to a wide range of products to meet patient needs, focusing on three pillars: the Microbiota Mission, orphan drugs and women’s health.
Biocodex key figures
- An international pharmaceutical company serving patients in more than 120 countries
- € 418M in revenue 2021
- 3 pillars: the Microbiota Mission, orphan drugs and women’s health
- Founded in 1953 to market Saccharomyces boulardii CNCM I-745®, the world’s first probiotic yeast strain for human medicine
- More than 1,600 employees of 42 nationalities
- 3 industrial facilities in France and Morocco
- 1 R&D center in France
- Subsidiaries in 20 countries
- 114 distribution partners
- An investor in 4 start-ups specialized in innovative health solutions
December 31, 2020 figures